OFFICIAL PUBLICATION OF

by its subsidiary APPco

Ozempic shortages to continue: Butler

Nicholas O’Donoghue 16/07/2024

Novo Nordisk “simply doesn’t have the factories” to meet growing demand for Ozempic, Health Minister says Shortages of Novo Nordisk’s diabetes medication, Ozempic (semaglutide) are likely to continue into 2025, while hormone replacement patches could be resolved by September, Mark Butler the Minister for Health and Aged Care warns. Speaking with Heidi Murphy on 3AW

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘We need more pharmacists’

Hmmm…how could we possibly get more pharmacists to go rural…hmmm….oh wait! What’s that thing called again? You know…it starts with…

John Smith

What does the future look like for CWH/Sigma shareholders?

But doesn’t this change as they slowly cripple their competition? It’s the classic Walmart move. Walk in, kill the competition…

John Smith

What does the future look like for CWH/Sigma shareholders?

I’m not sure if I’m just cynical but Ponraj came across as incredibly naive in this article. He was surprised…

John Smith

‘Doctor of Pharmacy’ title announced

Will any of this lead to direct claiming from Medicare for our new doctors?

John Smith

Ozempic shortages to continue: Butler

Previous Research Roundup

Next NAPSA seeks new chairs

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous Research Roundup

Next NAPSA seeks new chairs

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.